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Pathogens in the gastrointestinal tract exist within a vast 
population of microbes. We examined associations between 
pathogens and composition of gut microbiota as they relate 
to Shigella spp./enteroinvasive Escherichia coli infection. 
We analyzed 3,035 stool specimens (1,735 nondiarrheal 
and 1,300 moderate-to-severe diarrheal) from the Global 
Enteric Multicenter Study for 9 enteropathogens. Diarrheal 
specimens had a higher number of enteropathogens (diar-
rheal mean 1.4, nondiarrheal mean 0.95; p<0.0001). Rota-
virus showed a negative association with Shigella spp. in 
cases of diarrhea (odds ratio 0.31, 95% CI 0.17–0.55) and 
had a large combined effect on moderate-to-severe diar-
rhea (odds ratio 29, 95% CI 3.8–220). In 4 Lactobacillus 
taxa identified by 16S rRNA gene sequencing, the associa-
tion between pathogen and disease was decreased, which 
is consistent with the possibility that Lactobacillus spp. are 
protective against Shigella spp.–induced diarrhea. Bacterial 
diversity of gut microbiota was associated with diarrhea sta-
tus, not high levels of the Shigella spp. ipaH gene.
Diarrheal disease contributes substantially to illness and death in children in low-income countries (1,2). 
Recent investigations of enteric illness have shown many 
cases with >1 pathogen identified (3–5). The paradigm of 
1 pathogen and 1 disease has been questioned with the ad-
vent of microbiological and molecular detection methods 
that have lower limits of detection. Children in developing 
countries are exposed to an array of pathogenic organisms. 
Recent studies have shown a complex relationship between 
gut microbiota and diarrheal illness; children with severe 
illness tend to have a less diverse microbiota and a pre-
dominance of specific genera of organisms (6). Molecular-
based approaches to pathogen detection enhance the ability 
to quantify the abundance of pathogens shed in the stool.
Two recent studies of children in low-income coun-
tries have highlighted the need for pathogen quantitation. 
Lindsay et al., using the Global Enteric Multicenter Study 
(GEMS) specimen collection, found that 80% of controls 
and 89% of case-patients had detectable levels of Shigella 
spp. (7). To identify which children had shigellosis, Lind-
say et al. determined a quantitative threshold and, when 
applied, it identified twice as many cases compared with 
standard culture. Platts-Mills et al., in a study of popula-
tions with a high prevalence of malnutrition and enteric 
infections in Tanzania, compared samples taken before and 
during diarrheal episodes (8). They did not find an asso-
ciation between the presence of any pathogen and diarrhea 
for 15 pathogens studied (rotavirus, adenovirus, astrovi-
rus, norovirus, sapovirus, Cryptosporidium spp., Giardia 
lamblia, Campylobacter jejuni, Clostridium difficile, Sal-
monella spp., Shiga-toxigenic Escherichia coli, Shigella 
spp./enteroinvasive E. coli [EIEC], enterotoxigenic E. coli 
[ETEC], typical enteropathogenic E. coli [tEPEC], and 
enteroaggregative E. coli [EAEC]). However, when they 
considered quantity of pathogen on a continuous scale, 3 
organisms (rotavirus, astrovirus, and Shigella spp.) were 
associated with diarrhea.
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In disease-endemic settings, detection of multiple en-
teropathogens in asymptomatic and symptomatic children 
is common (4,9). Samples from one third of patients with 
diarrhea in a hospital study in Kolkata, India, contained 
>1 pathogen. Negative associations were demonstrated 
between Shigella spp. and rotavirus and Shigella spp. and 
Vibrio cholerae (3). However, a limitation of this study was 
that it was conducted only in patients with diarrhea. Thus, 
differential comparisons could not be made between patho-
gen associations in diarrheal and nondiarrheal samples. 
A recent study by Taniuchi et al. reported the etiology of 
diarrheal episodes by using molecular methods in Bangla-
deshi children during their first year of life. They found that 
multiple enteropathogens were present by the first month 
of life in stool specimens from healthy children and from 
children with diarrhea (4). If multiple pathogens are pres-
ent, they might interact to increase or decrease the prob-
ability of symptomatic infection. Bhavnani et al. reported 
synergistic effects in rotavirus–G. lamblia and rotavirus–E. 
coli infections, in which the presence of these co-occurring 
organisms increased the probability of disease (10).
The gut microbiota are composed of thousands of spe-
cies that might play a role in the risk for diarrhea. Some Lac-
tobacillus and Veillonella species are potentially protective 
against diarrhea or serve as markers of healthy gut microbio-
ta (11–13). Probiotic activity has been associated with some 
Lactobacillus spp., bifidobacteria, Veillonella spp., Strepto-
coccus spp., Enterococcus spp., nonpathogenic E. coli, and 
Saccharomyces boulardii (13). Randomized clinical trials 
have investigated the role of some Lactobacillus spp. in 
treating infectious diarrhea and identified that these organ-
isms can provide a benefit in the treatment of acute, infec-
tious, watery diarrhea in infants and young children (12). In 
this study, we examined relationships between Shigella spp./
EIEC, microbiota, and diarrhea by using 16S rRNA marker 
gene surveys of stool specimens from a large international 
study of diarrhea in children <5 years of age (9).
Methods
Study Design and Participants
We used stool specimens collected from children <5 years 
of age who participated in a matched case–control study 
of moderate-to-severe diarrhea sponsored by the GEMS 
consortium (14,15). In brief, the GEMS was a prospective 
case–control study of infants and young children at 7 sites 
in sub-Saharan Africa and southern Asia. Case-patients 
with moderate-to-severe diarrhea were enrolled when they 
came to a health clinic. Moderate-to-severe diarrhea eligi-
bility criteria included dehydration (sunken eyes, loss of 
normal skin turgor, or a decision to initiate intravenous hy-
dration), the presence of blood in the stool (dysentery), or 
a clinical decision to hospitalize the child. In the GEMS, 
matching controls (for sex, age, and community) were 
sampled from a demographic surveillance database of the 
area and included if they reported no diarrhea within the 
previous 7 days. For this study, 4 of the 7 GEMS sites (The 
Gambia, Mali, Kenya, and Bangladesh) elected to partici-
pate in further molecular characterization of their samples. 
When samples were sent for analysis, it was not required 
that their matched specimen be included, which resulted 
in disruption of matches. Including only samples with the 
complete matched set would have limited our sample size. 
Therefore, we included age and location as covariates in 
our analysis but did not analyze samples as matched sets.
All specimens for this study were collected during De-
cember 2007–December 2009. One specimen was collect-
ed for each child at the time of enrollment. The Institutional 
Review Boards at all participating institutions reviewed 
and approved the protocol.
Specimen Collection
Stool specimens were handled according to the GEMS pro-
tocol (16). DNA was isolated from frozen stool specimens 
by using a bead beater with 3-mm diameter solid glass 
beads (Sigma-Aldrich, St. Louis, MO, USA) and, subse-
quently, with 0.1-mm zirconium beads (BioSpec Products, 
Inc., Bartlesville, OK, USA) to disrupt cells. The cell slur-
ry was then centrifuged at 16,000 × g for 1 min, and the 
supernatant was processed by using QIAamp DNA Stool 
Extraction Kit (QIAGEN, Valencia, CA, USA). Extract-
ed DNA was precipitated with ethanol and shipped to the 
United States.
Detection of EAEC, tEPEC, ETEC, Rotavirus,  
Norovirus, G. lamblia, and Cryptosporidium spp.
Diagnostic microbiological methods for rotavirus, norovi-
rus, G. lamblia, Cryptosporidium spp., and diarrheagenic 
E. coli (EAEC, tEPEC, and ETEC) were conducted at each 
site as described by Panchalingham et al. (16). In brief, E. 
coli isolates were selected from MacConkey agar plates and 
tested by using motility indole ornithine medium. EAEC, 
tEPEC, and ETEC pathotypes were identified by using 
PCRs for known virulence determinants of each pathogen 
(ETEC: heat-labile and heat-stable enterotoxins; tEPEC: 
intimin [eae] and bundle-forming pilus; and EAEC: aatA 
and aaiC genes).
Rotavirus was detected by using the ProSpecT ELISA 
Rotavirus Kit (Oxoid, Basingstoke, UK). Norovirus geno-
groups GI and GII were detected by using a multiplex PCR 
specific for synthesized complementary DNA after viral 
RNA extraction and reverse transcription. G. lamblia and 
Cryptosporidium spp. were detected by using commer-
cially available immunoassays (TechLab, Blacksburg, VA, 
USA) following the manufacturer’s protocols. Although 
the GEMS study tested for other enteric pathogens, our 
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analysis included only pathogens that were present in ≥10 
specimens. This lower limit was chosen after examination 
of the distribution of positive samples for each pathogen 
and to avoid statistical testing with small sample sizes.
Quantitative PCR for Detection of ipaH Gene in  
Shigella spp. and EIEC
Each stool DNA specimen was tested by using a quantitative 
PCR (qPCR) for Shigella/EIEC that included the 7500/700 
Fast Real-Time PCR System, software V2·0·5, and SYBR 
green–based fluorescent dye (Applied Biosystems, Foster 
City, CA, USA). Details on primer design, PCR conditions, 
and standard curve analysis have been reported elsewhere 
(4,7,17). Shigella/EIEC was identified by using primers spe-
cific for the ipaH gene (7). We used a cutoff of 14,000 ipaH 
gene copies to distinguish children shedding low levels of 
Shigella spp. from those shedding high levels of Shigella 
spp. in their stools. The threshold was established by con-
structing receiver-operating characteristic curves to deter-
mine sensitivity and specificity of incremental increases in 
levels of ipaH compared with disease status and set on the 
basis of the point that maximized sensitivity and specificity 
(7). Stool specimens with high and low levels of ipaH indi-
cate the relative amount of Shigella spp. detected.
16S rRNA Gene Sequencing and Analysis and  
Identification of C. jejuni
DNA was amplified by using universal primers specific 
for the V1–V3 region of the 16S rRNA gene in bacteria 
(518R [5′-CAATTACCGCGGCTGCTGG-3′] and 27F 
[5′-AGAGTTTGATCCTGGCTCAG-3′]). Individual reads 
were filtered for quality by using custom in-house scripts 
that removed low-quality sequences as described (6). 
Remaining high-quality sequences were separated into 
sample-specific sets according to barcodes. Conservative 
operational taxonomic units (OTUs) were clustered by us-
ing DNACLUST with parameters (–r 1 and 99% identity 
clusters) to ensure that the definition of an OTU was con-
sistent across all samples (18). For taxonomic identifica-
tion, a representative sequence from each OTU was aligned 
to the Ribosomal Database (RDP) (rdp.cme.msu.edu, re-
lease 10.4) by using BLASTn (http://blast.ncbi.nlm.nih.
gov/Blast.cgi) with long word length (–W 100) to detect 
only nearly identical sequences (19). Sequences without a 
nearly identical match to the RDP (>100-bp perfect match 
and >97% identity, as defined by BLAST) were marked as 
being unassigned and assigned a unique OTU identifier. If 
a sample contained taxa classified as C. jejuni, we identi-
fied this sample as positive for C. jejuni.
Statistical Analysis
Associations between high levels of ipaH and each addi-
tional pathogen, stratified by diarrheal status, were assessed 
for children with moderate or severe diarrhea and for con-
trols by using separate logistic regression models with high 
levels of ipaH as the dependent variable. Logistic regres-
sion with moderate-to-severe diarrhea as the outcome of 
interest was then conducted to test for the interaction be-
tween high levels of ipaH and either 1) pathogenic micro-
organisms tested for by the GEMS or 2) species identified 
by 16S rRNA gene sequencing. All models were adjusted 
for potential confounding caused by location and age with 
categorical location and age terms in the model.
Statistical modeling was used to examine whether mi-
crobes interact to effect diarrhea risk. To assess whether 
the risk caused by having Shigella spp. and an additional 
microbe differed from the product of the risks caused by 
having each microbe separately (i.e., multiplicative in-
teraction), we used a logistic regression model with an 
interaction term containing the level of ipaH and the ad-
ditional microbe of interest (online Technical Appendix 
Figure, http://wwwnc.cdc.gov/EID/article/21/2/14-0795-
Techapp1.pdf). To assess whether the excess risk of hav-
ing ipaH and an additional microbe differed from the sum 
of the excess risk of having each separately (i.e., additive 
interaction), we estimated the relative excess risk caused by 
the interaction (RERI, also called the interaction contrast 
ratio [ICC]) (20–22). An RERI = 0 indicates no additive 
interaction, an RERI>0 suggests positive additive interac-
tion, and an RERI<0 suggests negative additive interaction. 
Ninety-five percent CIs were estimated by using the Hos-
mer-Lemeshow procedure (23,24). All statistical analysis 
was performed by using SAS version 9·2 (SAS Institute, 
Cary, NC, USA) and R 2.15 (25), and p values <0.05 were 
considered significant.
Results
A total of 3,035 (1,735 nondiarrheal and 1,300 diarrheal) stool 
specimens from children <5 years of age from The Gambia, 
Mali, Kenya, and Bangladesh were examined for Shigel-
la spp. by identification of ipaH by qPCR; for G. lamblia, 
Cryptosporidium spp., and rotavirus by ELISA; for norovirus 
by PCR; for EAEC, ETEC, or tEPEC by culture and subse-
quent PCR; and for C. jejuni by 16S rRNA gene sequencing. 
Characteristics of samples are shown in Table 1. Diarrheal 
samples had a significantly higher number of pathogens (diar-
rheal mean 1.4, nondiarrheal mean = 0.95; p<0.05).
Associations and Interaction Effects of  
Co-occurring Pathogens
In 69% (278/404) of samples with high levels of ipaH (71% 
of diarrheal samples with high levels of ipaH and 64% non-
diarrheal samples with high levels of ipaH), we identified 
an additional pathogen. In samples with low levels of ipaH, 
we identified an additional pathogen in 69% (1,815/2,631; 
80% of diarrheal samples with low levels of ipaH and 62% 
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of nondiarrheal samples with low levels of ipaH). After ad-
justing for age and location, rotavirus exhibited a negative 
association with high levels of ipaH in case-patients (odds 
ratio [OR] 0.31, 95% CI 0.17–0.55). In case-patients and 
controls, no other pathogen showed an association (Figure 
1; online Technical Appendix Table 1).
Of the 8 pathogens tested, none showed any interac-
tion effects. However, rotavirus was negatively associated 
with high levels of ipaH (Table 2), and only 15 samples 
that had high levels of ipaH were positive for rotavirus; 14 
of these 15 samples were diarrheal samples. The presence 
of rotavirus and high levels of ipaH resulted in an OR of 
29 (95% CI 3.8–220) for diarrheal risk. Although this point 
estimate was much higher than the expected additive effect 
of 11, this result and results of tests for interaction were not 
statistically significant (Table 3).
Interaction Effects of Lactobacillus and  
Veillonella Taxa
A total of 61 Lactobacillus and Veillonella taxa were 
identified by 16S rRNA gene sequencing. Analyses were 
limited to 31 taxa that co-occurred in samples with high 
levels of ipaH ≥10 times. We tested for interaction be-
tween high levels of ipaH and the identified 16S rRNA 
gene taxon by using a logistic regression model adjusted 
for age and location, including an interaction term be-
tween level of ipaH and taxon presence (online Technical 
Appendix Table 2). Five taxa showed significant nega-
tive multiplicative interactions identified by an interaction 
term with p ≤ 0·05. Of these taxa, Lactobacillus rumi-
nis (RERI –1.92, 95% CI –3.36 to 0.47), Lactobacillus 
DJF-RP24 (RERI –2.44, [95% CI –3.93 to 0.95), Lac-
tobacillus KLDS 1.0718 (RERI –1.93, 95% CI –3.56 to 
 
Table 1. Characteristics and pathogen abundance in children with cases of moderate-to-severe diarrhea and controls in low-income 
countries* 
Characteristic Cases, n = 1,300 Controls, n = 1,735 p value  Total, n = 3,035 
Male sex 727 (56) 965 (56) 0.8677 1,692 (56) 
Age, mo, mean (SD) 16.7 (12) 17.8 (12) 0.0073 17.39 (12) 
 0–5 156 (12) 177 (10) 0.1167 333 (11) 
 6–11 413 (32) 465 (27) 0.0028 878 (29) 
 12–23 431 (33) 617 (35) 0.1674 1,048 (35) 
 24–35 185 (14) 311 (18) 0.0064 496 (16) 
 36–59 115 (9) 165 (10) 0.5318 280 (9) 
Country NA NA NA NA 
 The Gambia 356 (27) 408 (23) 0.0151 764 (25) 
 Mali 103 (8) 114 (7) 0.1524 217 (7) 
 Kenya 636 (49) 779 (45) 0.0279 1,415 (47) 
 Bangladesh 205 (16) 434 (25) <0.0001 639 (21) 
ipaH gene copies ≥14,000 277 (22) 127 (7) <0.0001 404 (13) 
Rotavirus 183 (14) 41 (2) <0.0001 224 (7) 
Norovirus genogroups GI or GII 127 (10) 141 (8) 0.1146 268 (9) 
Giardia lamblia 230 (18) 373 (22) 0.0093 603 (20) 
Cryptosporidium spp. 142 (11) 87 (5) <0.0001 229 (7) 
tEPEC 106 (8) 104 (6) 0.0203 210 (7) 
EAEC 253 (19) 347 (20) 0.7124 600 (20) 
ETEC 181 (14) 148 (8) <0.0001 329 (11) 
Camplylobacter jejuni 341 (26) 264 (15) <0.0001 605 (20) 
Total pathogens, mean (SD) 1.4 (0.9) 0.9 (0.9) <0.0001 1.2 (0.9) 
*Values are no. (%) children unless otherwise indicated. NA, not applicable; tEPEC, typical enteropathogenic Escherichia coli; EAEC, enteroaggregative 
E. coli; ETEC, enterotoxigenic E. coli. 
 
Figure 1. Association of co-
occurring pathogens with high 
levels of ipaH gene of Shigella 
spp. in stool specimens of 
children with diarrhea (cases) 
and children without diarrhea 
(controls) in low-income 
countries. Dark circles indicate 
means, and error bars indicate 
95% CIs. tEPEC, typical 
enteropathogenic Escherichia 
coli; EAEC, enteroaggregative 
E. coli; ETEC, enterotoxigenic 
E. coli.
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0.29), and Lactobacillus TSK G32.2 (RERI -2.69, 95% 
CI -4.55 to 0.84]) showed additive interactions (Table 3). 
The combined effect of high levels of ipaH in the pres-
ence of L. ruminis, Lactobacillus DJF RP24, Lactobacil-
lus KLDS 1.0718, or Lactobacillus TSK G32.2 was low-
er than expected (Figure 2; online Technical Appendix 
Table 3), which suggested an antagonistic interaction or 
a decreased association with diarrhea when specific Lac-
tobacillus taxa were present than versus when they were 
absent. When we tested the 4 Lactobacillus taxa against 
8 additional pathogens; no additive interaction was ob-
served (online Technical Appendix Table 4).
16S rRNA Gene–based Bacterial Community Profiles
The proportional abundance of the 9 most common gen-
era identified by 16S rRNA marker gene sequencing dif-
fered among stool specimens with high and low levels of 
ipaH and among specimens from children with and with-
out diarrhea (Figure 3). Overall composition of diarrheal 
stool specimens had an increased relative proportional 
abundance of facultative anaerobes when compared with 
composition of nondiarrheal stool specimens, even when 
diarrheal stool specimens had low levels of ipaH (mean 
diarrheal specimens 0.47, mean nondiarrheal specimens 
0.22; p<0.0001). Overall, diarrheal stool specimens with 
high levels of ipaH had the  lowest proportion abundance 
of Prevotella spp. (0.11), diarrheal stool samples with 
low levels of ipaH had the second lowest proportional 
abundance (0.15), and nondiarrheal stool specimens 
with high and low levels of ipaH had similar proportion 
abundances for Prevotella spp. (0.25 and 0.24, respec-
tively; p = 0.63).
Shigella spp. identified by the ipaH qPCR were a sub-
set of the genera Escherichia/Shigella identified by 16S 
rRNA gene sequencing, but could not be distinguished 
from commensal strains. Diarrheal specimens had a larger 
proportion of members of the genera Escherichia/Shigel-
la (p<0.0001) than nondiarrheal specimens, regardless of 
levels of ipaH. However, diarrheal stool specimens with 
high levels of ipaH had a significantly higher proportion of 
Escherichia/Shigella sequences (31%; p<0.0001) than did 
diarrheal stool specimens with low levels of ipaH.
Members of the genus Veillonella was found equally 
in diarrheal and nondiarrheal stool specimens. Streptococci 
 
Table 2. Interaction between level of Shigella spp./EIEC ipaH gene and rotavirus and association with moderate-to-severe diarrhea in 
children in low-income countries* 
Rotavirus status† 
Low level of ipaH gene 
 
High level of  ipaH gene OR (95% CI) for ipaH 
gene within strata of 
rotavirus status 
No. with MSD/ 
no. without MSD OR (95% CI) 
No. with MSD/ 
no. without MSD OR (95% CI) 
Negative 854/1,568 1.00 (reference)  263/126 4.01 (3.18–5.05) 4.01 (3.18–5.05) 
Positive 169/40 7.56 (5.29–10.80)  14/1 28.85 (3.77–220) 3.82 (0.48–30.00) 
OR (95% CI) for rotavirus 
within strata of ipaH gene 
status 
NA 7.55 (5.29–10.80)  NA 7.20 (0.93–55.57) Expected additive = 
10.57 
*EIEC, enteroinvasive Escherichia coli; MSD, moderate-to-severe diarrhea; OR, odds ratio; NA, not applicable. 
†Model is unconditional and adjusted for age and location. 
 
 
Table 3. Measures of additive and multiplicative interactions of co-occurrence of Shigella spp. and another pathogen or Lactobacillus 
spp. in children in low-income countries* 
Pathogen or 
organism OR10† (95% CI) OR01‡ (95% CI) OR11§ (95% CI) RERI (95% CI) 
Additive 
p value 
Multiplicative 
p value 
C. jejuni 3.84 (2.98–4.95) 1.97 (1.62–2.40) 5.55 (3.67–9.15) 0.79 (2.15 to 3.73) 0.62 0.29 
ETEC 3.77 (2.97–4.80) 1.69 (1.32–2.18) 4.65 (2.32–9.30) 0.15 (3.20 to 3.52) 0.92 0.41 
tEPEC 3.69 (2.91–4.69) 1.36 (1.02–1.83) 4.09 (2.01–8.33) 0.03 (2.99 to 3.06) 0.99 0.61 
Cryptosporidium spp. 3.79 (2.99–4.81) 2.40 (1.78–3.24) 4.95 (2.28–10.75) 0.27 (4.27 to 3.73) 0.91 0.16 
Rotavirus 4.01 (3.18–5.05) 7.56 (5.29–10.80) 28.85 (3.77–220) 18.29 (40.32 to 76.91) 0.54 0.96 
Norovirus 
genogroups GI or GII 
3.65 (2.87–4.64) 1.14 (0.86–1.51) 4.00 (2.08–7.71) 0.21 (2.56 to.98) 0.88 0.91 
EAEC 3.59 (2.78–4.63) 0.87 (0.71–1.07) 3.29 (2.06–5.26) 0.17 (1.92 to 1.58) 0.85 0.86 
Giardia lamblia 3.65 (2.84–4.69) 0.83 (0.68–1.02) 2.70 (1.63–4.49) 0.78 (2.83 to 0.83) 0.35 0.70 
Lactobacillus taxon      
 KLDS 1.0718 4.10 (3.19–5.26) 1.25 (1.01–1.55) 2.42 (1.41–4.13) 1.93 (3.56 to 0.29) 0.02 0.02 
 L. salivarius 4.12 (3.20–5.31) 1.77 (1.45–2.16) 3.88 (2.35–6.38) 1.02 (3.18 to 1.14) 0.36 0.03 
 L. ruminis 4.30 (3.19–5.79) 0.82 (0.69–0.96) 2.20 (1.55–3.13) 1.92 (3.36 to 0.47) 0.01 0.05 
 DJF RP24 4.59 (3.41–6.16) 0.85 (0.72–0.99) 1.99 (1.39–2.85) 2.44 (3.93 to 0.95) 0.001 0.01 
 TSK G32–2 3.89 (3.08–4.92) 1.40 (1.07–1.85) 1.60 (0.59–4.30) 2.69 (4.55 to 0.84) 0.004 0.02 
*OR, odds ratio; RERI, relative excess risk caused by the interaction; ETEC, enterotoxigenic Escherichia coli; tEPEC, typical enteropathogenic E. coli; 
EAEC, enteroaggregative E. coli. Boldface indicates significance (p0.05). Under an additive interaction, OR11 – OR10 – OR01 + 1 = 0. Under a 
multiplicative interaction, OR11 = OR10OR01. 
†OR caused by having a high level of the ipaH gene alone (in the absence of the other pathogen or Lactobacillus taxon). 
‡OR caused by having the other pathogen or Lactobacillus taxon alone (in the absence of a high level of the ipaH gene). 
§OR caused by having a high level of the ipaH gene and another pathogen or Lactobacillus taxon (relative to having neither). 
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were found more often in diarrheal stool specimens, re-
gardless of levels of ipaH. There was no association be-
tween Shannon diversity indices and levels of ipaH (p = 
0.95), although diversity was significantly associated with 
age, location, and moderate-to-severe diarrhea (p<0.0001, 
p = 0.004, and p<0.0001, respectively) (Figure 4).
Discussion
In this study, we used qPCR and 16S rRNA gene sequenc-
ing to identify interactions between Shigella/EIEC and 
co-occurring enteric pathogens or microbes within the gut 
microbiota in children with moderate-to-severe diarrhea. 
We explored these interactions in stool specimens obtained 
from children with and without diarrhea who participated 
in the international GEMS study. We used detection of 
the ipaH gene as an indicator of Shigella/EIEC infection 
because this molecular method is highly sensitive and 
specific (4,26,27). Use of quantitative identification meth-
ods, rather than colonization (7,8), is advantageous for 
identifying true disease associations. We found that 69% 
(1,815/2,631) of stool samples with high levels of ipaH 
had a co-occurring pathogen.
This study confirms the findings of the negative asso-
ciation between rotavirus and Shigella spp. in polymicro-
bial infections in diarrheal patients in India and The Gam-
bia (Shigella spp./rotavirus: OR 0.36, 95% CI 0.14–0.92) 
(3,28). Although we identified correlations between rotavi-
rus and Shigella spp. as determined by levels of ipaH, no 
pathogen showed an antagonistic or synergistic interaction 
on the odds of moderate-to-severe diarrheal illness. Al-
though all but 1 of the rotavirus-positive samples that had 
high levels of ipaH were associated with diarrhea cases, 
the negative association between these pathogens gave us 
limited sample size to assess a possible synergistic effect. 
A synergistic effect between high levels of ipaH and ro-
tavirus (RERI/ICC 9.9, 95% CI 2.6–28.4) was previously 
observed in Ecuador, and it was concluded that pathogenic 
potential appears to be enhanced during co-infection (10). 
Our RERI/ICC was 18, but the effect was not significant, 
possibly because of small sample size.
Figure 2. Departure from additivity between level of ipaH gene 
and presence of Lactobacillus taxon TSK G32-2 on odds of 
moderate-to-severe diarrhea in children in low-income countries. 
The reference group is TSK G32-2 negative, low level of ipaH. 
The observed combined joint effect of a high level of the ipaH 
gene and TSK G32-2 was lower than the expected additive effect. 
Gray bars indicate effect of TSK G32-2; black bars indicate effect 
of high levels of ipaH; and white bar indicates observed joint 
effect of TSK G32-2 and high levels of ipaH. Neg, negative; Pos, 
positive; Exp, expected; Obs, observed.
Figure 3. Overall 16S rRNA 
gene–based bacterial community 
profiles (proportional abundance) 
of diarrheal samples with high 
levels of ipaH gene  
(n = 277), diarrheal samples with 
low levels of ipaH gene  
(n = 1,023), nondiarrheal 
samples with high levels of ipaH 
gene (n = 127), and nondiarrheal 
samples with low levels of ipaH 
gene (n = 1,608) from children 
in low-income countries. Other 
indicates sequences that were 
not identified as 1 of the 9 most 
abundant taxa or did not have 
good (>100 bp exact match, 
>97% identity) matches with 
isolate sequences from the 
Ribosomal Database Project (19).
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The GEMS was designed as a matched case–control 
study of thousands of stool samples from persons matched 
by age, sex, community, and time. A possible limitation of 
our methods is that we did not use matched pairs but rather 
adjusted for country-level location and age by using statis-
tical modeling. This method was used because of the large 
number of broken matched pairs. Thus, inclusion of all 
samples greatly increased our sample size. Generally, the 
lack of an appropriate matched analysis biases the effect 
on estimates toward the null. However, studies have shown 
that including samples with missing data and adjusting by 
using confounding terms is valuable, particularly with a 
larger sample size (29,30). We adjusted for location at the 
country level, and the GEMS matched case-patients at the 
community level, which could fail to adequately address 
bias, particularly when one considers that the distribution 
of case-patients and controls differed at multiple sites and 
that Shigella spp. are more common in Bangladesh. An 
additional limitation of our study design is that, given a 
cross-sectional study sample set, we were unable to iden-
tify temporal associations and to attribute cause and effect. 
Furthermore, associations between pathogens and taxa 
may be explained by seasonality, and further work should 
be conducted to investigate this as a possible explanation. 
Finally, the 16S rRNA gene-sequencing method used to 
identify taxa of interest is limited because our identification 
was only as precise as the RDP attributed taxonomy. Thus, 
further characterization and species-specific identification 
are warranted in uncultured bacteria such as Lactobacillus 
KLDS 1.0718.
A previous study showed cross-sectional differences 
in stool microbiota of children with diarrhea compared 
with children without diarrhea in low-income countries 
(6). Our study showed that the composition of microbiota 
is more closely associated with diarrheal status than with 
co-infection by Shigella spp./EIEC as measured by high 
levels of ipaH. Microbiota in stools of children without 
diarrhea but who had high levels of ipaH (i.e., were colo-
nized with Shigella spp./EIEC) were more similar to mi-
crobiota of healthy children with low levels of ipaH than 
microbiota in samples from children with diarrhea and 
high levels of ipaH.
In low-income countries, infection/colonization with 
pathogens occurs commonly in persons without diarrhea. 
Our study found little evidence of interaction between Shi-
gella spp. and co-occurring pathogens. Although the cross-
sectional study design precludes strong statements of cause 
and effect, our data are consistent with the possibility that 
some Lactobacillus taxa naturally occurring in the gut and 
are protective against Shigella spp.–induced diarrhea. Fu-
ture studies should continue to consider the effects of co-
occurring species.
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